Results 161 to 170 of about 67,208 (298)

Pathogen-Specific Hypoalbuminemia in Patients with Sepsis: A Retrospective Study with Propensity Score Analysis. [PDF]

Infect Drug Resist
Shao S, Yang J, Yin H, Zheng Y, Yu X, Zhou D, Feng J, Wang J.   +7 more
europepmc   +1 more source

Exploring the Gut‐Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder Function

The Prostate, Volume 86, Issue 8, Page 900-910, June 2026.
ABSTRACT Background Benign prostatic hyperplasia (BPH) is a common urologic condition in aging men, often linked to systemic inflammation and metabolic dysfunction. Emerging evidence suggests that the gut microbiome may contribute to prostate health and disease.
Jonathan Surber, Marie Lork, Yasser Morsy, Michael Scharl, Daniel Stephan Engeler, Janine Langenauer, Lukas John Hefermehl, Anna Ebner, Basil Kaufmann, Manuela Hunziker, Daniel Eberli, Uwe Bieri, Cédric Poyet   +12 more
wiley   +1 more source

A not too Fragile Bacteroides. [PDF]

J Community Hosp Intern Med Perspect
Guru S, Jaafar N, Sharma R, Bai P.
europepmc   +1 more source

Metformin as a Multifaceted Therapeutic Agent for Gastrointestinal Diseases: Mechanisms, Clinical Efficacy, and Future Directions

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT The high prevalence of gastrointestinal (GI) diseases and their significant impact on the quality of life require new therapeutic strategies. The development of novel therapeutic strategies should prioritize targeting the fundamental pathophysiological mechanisms underlying these diseases, including inflammation, cellular proliferation, and ...
Sayedeh Azimeh Hosseini, Hassan Valadbeigi, Seyedeh Mahdieh Khoshnazar, Saeed Khoshnood, Shahab Falahi, Delsuz Rezaee, Ali Hematian, Mohammad Hossein Haddadi   +7 more
wiley   +1 more source

Interplay between viral infections and gut microbiota dysbiosis: Mechanisms and therapeutic potential. [PDF]

World J Gastroenterol
Velikova T, Ali H, Batselova H, Chervenkov L, Miteva D, Peruhova M, Gulinac M, Tomov L, Mitova-Mineva Y, Velev V.   +9 more
europepmc   +1 more source

Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 4, May 2026.
Central illustration: Pathophysiological mechanisms linking diabetes mellitus and cardiovascular disease. Chronic hyperglycaemia, insulin resistance, and low‐grade inflammation contribute to endothelial dysfunction, myocardial fibrosis, and cardiomyocyte apoptosis.
Lilian Anagnostopoulou, Nikolaos Ktenopoulos, Anastasios Apostolos, Christos Fragoulis, Panayotis Vlachakis, Paschalis Karakasis, Marios Sagris, Nikias Milaras, Maria Drakopoulou, Andreas Synetos, Ioannis Kyriazis, Ioannis Ioannidis, Costas Tsioufis, Konstantinos Toutouzas   +13 more
wiley   +1 more source

From Sound to Silence: Cerebellar Abscesses and Herniation Due to Cochlear Implant Infection With <i>Escherichia coli</i> and <i>Bacteroides fragilis</i>. [PDF]

Case Rep Infect Dis
Molfetta C, Biswas R, Pickard M, Salim T, Nuñez C.   +4 more
europepmc   +1 more source

Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This review synthesises current knowledge on gut microbiome involvement in obesity and hypertension, evaluates microbiome‐based therapeutic strategies, and identifies critical research gaps to guide future investigations aimed at mitigating the dual pandemics.
Andrej Belančić, Almir Fajkić, Yusuf Ziya Sener, Ana Jelaković, Lejla Alić, Elvira Meni Maria Gkrinia, Donatella Verbanac, Bojan Jelaković   +7 more
wiley   +1 more source

Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients. [PDF]

PLoS One
Wang G, Liu L, Zhang H, Mao P, Lu S, Zhang X, Li X, Song C.   +7 more
europepmc   +1 more source

Fungal Polysaccharides as Next‐Generation Bioactive: Advances in Structure–Activity Mapping, Mode of Action, and Biotechnological Horizons

Food Frontiers, Volume 7, Issue 3, May 2026.
ABSTRACT Fungal polysaccharides (FPs) represent a diverse class of bioactive macromolecules widely studied for their nutritional, therapeutic, and biotechnological value. This review synthesizes recent advances (2020–2025) in the structural characterization, biological functions, and translational potential of FPs.
Muhammad Aaqil, Feng Zhang, Jingchuan Zheng, Muhammad Kamil, Yuwei Guo, Cunchao Zhao, Yang Tian   +6 more
wiley   +1 more source